Enhanced therapeutic efficacy of G207 for the treatment of glioma through Musashi1 promoter retargeting of gamma34.5-mediated virulence.

Source:http://linkedlifedata.com/resource/pubmed/id/16163378

Download in:

View as

General Info

PMID
16163378